Alkixen 250 mg contains Crizotinib, a targeted therapy used to treat a specific type of lung cancer known as ALK-positive non-small cell lung cancer (NSCLC). This medication is part of a newer generation of treatments that focus on blocking the growth of cancer cells while limiting damage to healthy tissues. https://nertrader.com/product/alkixen-250-mg-crizotinib-60-capsules-JkFKCB